CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor Novo Nordisk, will still be covered under plans managed by CVS Caremark.

The coverage change only applies to employer and union insurance plans ... Wegovy will enable more employers to provide coverage for the weight loss category," CVS Health Vice President of External ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

The coverage change applies to CVS Caremark’s most common formulary template, which represents between 25 and 30 million individuals overall. ... CVS Health said.